Bioventus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

Rhea-AI Summary

Bioventus (Nasdaq: BVS), a global leader in innovations for active healing, has announced its participation in the upcoming Morgan Stanley Global Healthcare Conference. Mark Singleton, the company's Senior Vice-President and Chief Financial Officer, will engage in a fireside chat on September 10, 2025, at 1:05 p.m. ET.

Investors can access a live webcast of the presentation through the "Investors" section of Bioventus's website at www.bioventus.com, with a replay option available after the event.

News Market Reaction – BVS

-2.49%

-2.49% Session close to close

In the Sep 3 session, BVS declined 2.49%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DURHAM, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, Bioventus Senior Vice-President and Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on Wednesday, September 10, 2025, at 1:05 p.m. ET.

A live webcast of the presentation will be available on the “Investors” section of the Company’s website at www.bioventus.com and will be available for replay on that site following the event.

About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com, and follow the Company on LinkedIn and X. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

Investor and Media Contact:
Dave Crawford
919-474-6787
dave.crawford@bioventus.com

FAQ

When is Bioventus (BVS) presenting at the Morgan Stanley Healthcare Conference 2025?

Bioventus will present on Wednesday, September 10, 2025, at 1:05 p.m. ET through a fireside chat.

Who will represent Bioventus (BVS) at the Morgan Stanley Healthcare Conference?

Mark Singleton, Bioventus's Senior Vice-President and Chief Financial Officer, will represent the company.

How can investors watch the Bioventus (BVS) Morgan Stanley conference presentation?

Investors can watch the live webcast through the "Investors" section of Bioventus's website at www.bioventus.com. A replay will be available after the event.

What topics will Bioventus (BVS) discuss at the Morgan Stanley Healthcare Conference?

Bioventus's CFO will participate in a fireside chat, though specific discussion topics were not disclosed in the announcement.